[go: up one dir, main page]

AU2002364431A1 - Polypeptides inducing apoptosis, polynucleotides encoding them and therapeutic uses thereof - Google Patents

Polypeptides inducing apoptosis, polynucleotides encoding them and therapeutic uses thereof

Info

Publication number
AU2002364431A1
AU2002364431A1 AU2002364431A AU2002364431A AU2002364431A1 AU 2002364431 A1 AU2002364431 A1 AU 2002364431A1 AU 2002364431 A AU2002364431 A AU 2002364431A AU 2002364431 A AU2002364431 A AU 2002364431A AU 2002364431 A1 AU2002364431 A1 AU 2002364431A1
Authority
AU
Australia
Prior art keywords
polynucleotides encoding
therapeutic uses
inducing apoptosis
polypeptides
polypeptides inducing
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2002364431A
Inventor
Mireille Lafage
Monique Lafon
Stephanie Lay
Christophe Prehaud
Maria-Isabel Thoulouze
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Institut Pasteur
Original Assignee
Institut Pasteur
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Institut Pasteur filed Critical Institut Pasteur
Publication of AU2002364431A1 publication Critical patent/AU2002364431A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K39/39Medicinal preparations containing antigens or antibodies characterised by the immunostimulating additives, e.g. chemical adjuvants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K2039/555Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511Organic adjuvants
    • A61K2039/55516Proteins; Peptides
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K2319/00Fusion polypeptide
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2740/00Reverse transcribing RNA viruses
    • C12N2740/00011Details
    • C12N2740/10011Retroviridae
    • C12N2740/13011Gammaretrovirus, e.g. murine leukeamia virus
    • C12N2740/13041Use of virus, viral particle or viral elements as a vector
    • C12N2740/13043Use of virus, viral particle or viral elements as a vector viral genome or elements thereof as genetic vector
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2760/00MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
    • C12N2760/00011Details
    • C12N2760/20011Rhabdoviridae
    • C12N2760/20111Lyssavirus, e.g. rabies virus
    • C12N2760/20122New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Mycology (AREA)
  • Epidemiology (AREA)
  • Virology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AU2002364431A 2001-12-07 2002-12-06 Polypeptides inducing apoptosis, polynucleotides encoding them and therapeutic uses thereof Abandoned AU2002364431A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
CA002364150A CA2364150A1 (en) 2001-12-07 2001-12-07 Polypeptides inducing apoptosis, polynucleotides that code for them and their therapeutic applications
CA2,364,150 2001-12-07
PCT/FR2002/004211 WO2003048198A2 (en) 2001-12-07 2002-12-06 Polypeptides inducing apoptosis, polynucleotides encoding them and therapeutic uses thereof

Publications (1)

Publication Number Publication Date
AU2002364431A1 true AU2002364431A1 (en) 2003-06-17

Family

ID=4170716

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2002364431A Abandoned AU2002364431A1 (en) 2001-12-07 2002-12-06 Polypeptides inducing apoptosis, polynucleotides encoding them and therapeutic uses thereof

Country Status (3)

Country Link
AU (1) AU2002364431A1 (en)
CA (1) CA2364150A1 (en)
WO (1) WO2003048198A2 (en)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2239330A1 (en) * 2009-04-07 2010-10-13 Institut Pasteur Neuron generation, regeneration and protection
EP2581384A1 (en) 2011-10-11 2013-04-17 Institut Pasteur Products useful for the treatment of malignant neoplasms of the human nervous system
EP2592091B1 (en) 2011-11-08 2017-09-20 Institut Pasteur High MAST2-affinity polypeptides and uses thereof

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2563434B1 (en) * 1984-04-25 1986-07-25 Transgene Sa Rabies vaccine and process for its preparation
CA1337115C (en) * 1987-07-30 1995-09-26 Bernhard Dietzschold Vaccination against rabies-related diseases
AU7081896A (en) * 1995-10-05 1997-04-28 Microbix Biosystems Inc. Rabies recombinant adenovirus
US7074413B2 (en) * 2000-03-23 2006-07-11 Thomas Jefferson University Genetically engineered rabies recombinant vaccine for immunization of stray dogs and wildlife

Also Published As

Publication number Publication date
WO2003048198A2 (en) 2003-06-12
CA2364150A1 (en) 2003-06-07
WO2003048198A3 (en) 2004-04-22

Similar Documents

Publication Publication Date Title
IL159015A0 (en) Polypeptides, their preparation and use
IL160229A0 (en) Polynucleotides, polypeptides encoded thereby and their use
AU2001265009A1 (en) Human polynucleotides and polypeptides encoded thereby
IL158397A0 (en) Polypeptides, their preparation and their use
EP1446419A4 (en) Therapeutic polypeptides, nucleic acids encoding the same, and methods of use
AU2001280608A1 (en) Human polynucleotides and polypeptides encoded thereby
AU2002256276A1 (en) Novel expansin polynucleotides, related polypeptides and methods of use
AU2002334781A1 (en) Novel human proteins, polynucleotides encoding them and methods of using the same
AU2002327676A1 (en) Novel polynucleotides and proteins encoded thereby
AU2002364431A1 (en) Polypeptides inducing apoptosis, polynucleotides encoding them and therapeutic uses thereof
AU2002309646A1 (en) Novel human proteins, polynucleotides encoding them and methods of using the same
IL161234A0 (en) Ngzipa, ngzipd, pgzipa and pgzipd polynucleotides and polypeptides and uses thereof
AU2001260413A1 (en) Rh116 polypeptides and its fragments and polynucleotides encoding said polypeptides and therapeutic uses
AU2002303284A1 (en) Protection-of-telomere-1 (pot-1) protein and encoding polynucleotides
WO2003023002A9 (en) Novel human proteins, polynucleotides encoding them and methods of using the same
AU2002303232A1 (en) Novel human proteins, polynucleotides encoding them and methods of using the same
AU2002318186A1 (en) Novel human kielin-like proteins and polynucleotides encoding the same
WO2002072611A8 (en) Novel human egf-family proteins and polynucleotides encoding the same
AU2002254163A1 (en) Novel human proteins, polynucleotides encoding them and methods of using the same
AU2002322404A1 (en) Novel human proteins, polynucleotides encoding them and methods of using the same
AU2001239378A1 (en) Ssa-56kda polypeptide and its fragments and polynucleotides encoding said polypeptides and therapeutic uses
AU2003213355A1 (en) Novel receptor polypeptides and polynucleotides encoding the same
AU2002228079A1 (en) Haemophilus influenza basb212 polynucleotides, polypeptides and use thereof
AU2002306913A1 (en) Novel human asparaginases and polynucleotides encoding the same
AU2002251433A1 (en) Gssp3 polynucleotides and polypeptides and uses thereof

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase